Evidence map›Paper›PMID 24569509›Full record

ArticleShock (Augusta, Ga.)2014

Abandon the mouse research ship? Not just yet!

Marcin F Osuchowski, Daniel G Remick, James A Lederer, Charles H Lang, Ansgar O Aasen, Mayuki Aibiki, Luciano C Azevedo, Soheyl Bahrami, Mihaly Boros, Robert Cooney and 17 more

Abstract readComment
In one paragraph

Article in Shock (Augusta, Ga.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Omics of endothelial cell dysfunction in sepsis.Vascular biology (Bristol, England) · 2022
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Marcin F Osuchowski*Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in the AUVA Research Center, Vienna, Austria; †Boston University School of Medicine and ‡Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; §Pennsylvania State College of Medicine, Hershey, Pennsylvania; ∥Oslo University Hospital, Oslo, Norway; ¶Ehime University, Matsuyama, Japan; **Research and Education Institute, Hospital Sirio-Libanes, São Paulo, Brazil; ††Institute of Surgical Research, University of Szeged, Szeged, Hungary; ‡‡State University of New York Upstate Medical University, Syracuse, New York; §§Department of Biological and Environmental Sciences, University of Messina, Messina, Italy; ∥∥Southern Medical University Guangzhou, Guangzhou, China; ¶¶Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts; ***Chiba University Graduate School of Medicine, Chiba, Japan; †††Washington University School of Medicine, St Louis, Missouri; ‡‡‡University of Kentucky College of Medicine, Lexington, Kentucky; §§§Ulm Medical University Clinic, Ulm, Germany; ∥∥∥Division of Infectious Diseases, Department of Medicine, Hospital São Paulo-Escola Paulista de Medicina, Federal University of São Paulo, Sao Paulo, Brazil; ¶¶¶University of Indonesia, Jakarta, Indonesia;****The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom; ††††University of Brussels, Erasme University Hospital, Brussels, Belgium; ‡‡‡‡The University of Michigan Medical School, Ann Arbor, Michigan; §§§§Burns Institute, First Hospital Affiliated to the Chinese PLA General Hospital, Beijing, China; ∥∥∥∥Chang Gung Memorial Hospital, Taipei, Taiwan; ¶¶¶¶Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and *****University of Alabama at Birmingham, Birmingham, Alabama.
Daniel G Remick
James A Lederer
Charles H Lang
Ansgar O Aasen
Mayuki Aibiki
Luciano C Azevedo
Soheyl Bahrami
Mihaly Boros
Robert Cooney
Salvatore Cuzzocrea
Yong Jiang
Wolfgang G Junger
Hiroyuki Hirasawa
Richard S Hotchkiss
Xiang-An Li
Peter Radermacher
Heinz Redl
Reinaldo Salomao
Amin Soebandrio
Christoph Thiemermann
Jean-Louis Vincent
Peter Ward
Yong-Ming Yao
Huang-Ping Yu
Basilia Zingarelli
Irshad H Chaudry

Funding

SEPSIS INDUCED INSULIN RESISTANCE IN DIABETESR01GM038032 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI LANG, CHARLES H. · 1992 to 2015
$5.4M
Neutrophil activation and traumaR01GM060475 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JUNGER, WOLFGANG G · 2001 to 2016
$3.8M
Impact of Biological, Clinical, and Social Determinants on Trauma and Trauma OutcomesT32GM086308 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Alik Farber, Daniel G. Remick · 2010 to 2026
$3.5M
Synthetic HDL_a potential sepsis therapyR01GM113832 · NIGMS · UNIVERSITY OF KENTUCKY · PI LI, XIANG-AN, SCHWENDEMAN, ANNA · 2015 to 2019
$3.0M
Purinergic regulation of T cellsR01GM051477 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JUNGER, WOLFGANG G · 2003 to 2016
$2.5M
Injury-Specific Activation of the Immune SystemR01AI092905 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI LEDERER, JAMES A. · 2011 to 2015
$2.0M
MAINTENANCE OF ORGAN FUNCTION FOLLOWING INJURYR01GM039519 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHAUDRY, IRSHAD H · 1988 to 2012
$1.6M
Role of SR-BI in LPS detoxificationR01GM085231 · NIGMS · UNIVERSITY OF KENTUCKY · PI LI, XIANG-AN · 2008 to 2012
$1.5M
Adenosine and Oxygen Modulate Antimicrobial DefensesR01GM097320 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI REMICK, DANIEL G., SITKOVSKY, MICHAIL · 2011 to 2014
$1.2M
Mechanism of adrenal insufficiency as a risk factor for sepsisR01GM121796 · NIGMS · UNIVERSITY OF KENTUCKY · PI LI, XIANG-AN · 2017 to 2020
$1.2M
NIAID NIH HHS R01 AI092905NIGMS NIH HHS R01 GM038032NIGMS NIH HHS R01 GM039519NIGMS NIH HHS R01 GM051477NIGMS NIH HHS R01 GM060475NIGMS NIH HHS R01 GM085231NIGMS NIH HHS R01 GM097320NIGMS NIH HHS R01 GM113832NIGMS NIH HHS R01 GM121796NIGMS NIH HHS T32 GM086308
6 · The paper itself

Abstract

Many preclinical studies in critical care medicine and related disciplines rely on hypothesis-driven research in mice. The underlying premise posits that mice sufficiently emulate numerous pathophysiologic alterations produced by trauma/sepsis and can serve as an experimental platform for answering clinically relevant questions. Recently, the lay press severely criticized the translational relevance of mouse models in critical care medicine. A series of provocative editorials were elicited by a highly publicized research report in the Proceedings of the National Academy of Sciences (PNAS; February 2013), which identified an unrecognized gene expression profile mismatch between human and murine leukocytes following burn/trauma/endotoxemia. Based on their data, the authors concluded that mouse models of trauma/inflammation are unsuitable for studying corresponding human conditions. We believe this conclusion was not justified. In conjunction with resulting negative commentary in the popular press, it can seriously jeopardize future basic research in critical care medicine. We will address some limitations of that PNAS report to provide a framework for discussing its conclusions and attempt to present a balanced summary of strengths/weaknesses of use of mouse models. While many investigators agree that animal research is a central component for improved patient outcomes, it is important to acknowledge known limitations in clinical translation from mouse to man. The scientific community is responsible to discuss valid limitations without overinterpretation. Hopefully, a balanced view of the strengths/weaknesses of using animals for trauma/endotoxemia/critical care research will not result in hasty discount of the clear need for using animals to advance treatment of critically ill patients.

Indexed as

GenomicsAnimalsFemaleHumansInflammationMale

Identifiers

PMID24569509
PMCPMC4139038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.